CuePath Innovation Inc. (“CuePath”, or the "Company") announced that the Company has closed its Seed Round, oversubscribed at USD$1.8M. This includes a concurrent investment from Genome BC's Industry Innovation Program (I2) Fund; seed funds E-Fund and Canada Innovation Acceleration Investment; and a group of technology, healthcare, and social impact Angel investors. CuePath is a healthcare [...]